Achieve Life Sciences Inc (NQ: ACHV )
9.750
USD
+0.660
(+7.26%)
Official Closing Price
Updated: 7:59 PM EST, Jan 15, 2021
Add to My Watchlist
Press releases about Achieve Life Sciences Inc
From ACCESSWIRE
Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option
December 07, 2020
From PR Newswire
Achieve Life Sciences Announces Pricing of $15 Million Public Offering
December 03, 2020
From PR Newswire
Achieve Life Sciences Announces Proposed Public Offering
November 30, 2020
From PR Newswire
Achieve Reports Financial Results for Third Quarter 2020 and Provides Corporate and Cytisinicline Development Update
November 12, 2020
From PR Newswire
Achieve Life Sciences to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020
October 29, 2020
From PR Newswire
Achieve Life Sciences to Host Smoking Cessation Key Opinion Leader Virtual Roundtable on November 17th, 2020
October 27, 2020
From PR Newswire
Achieve Life Sciences Announces to Present at the MicroCap Best Ideas Conference, October 13, 2020
October 08, 2020
From ACCESSWIRE
Achieve Life Sciences Announces Start of Phase 3 ORCA-2 Clinical Trial Evaluating Cytisinicline for Smoking Cessation
October 07, 2020
From PR Newswire
Achieve Life Sciences Announces Appointment of John Bencich to Chief Executive Officer & Dr. Cindy Jacobs to President
September 30, 2020
From PR Newswire
From PR Newswire
Achieve Life Sciences Announces Results from Evaluation of Cytisinicline (cytisine) versus Chantix® (varenicline) in 5-HT3 Receptor Binding Assay Study
September 18, 2020
From PR Newswire
Achieve Life Sciences Announces Presentation of Cytisinicline Data at the 20th Annual Society for Research on Nicotine & Tobacco Europe (SRNT-E) Virtual Conference
September 10, 2020
From PR Newswire
Achieve Life Sciences to Present at Upcoming Investor Conferences
September 03, 2020
From PR Newswire
Achieve Reports Financial Results for Second Quarter 2020 and Provides Update on Cytisinicline Development Program
August 06, 2020
From PR Newswire
From PR Newswire
Achieve Life Sciences Announces Proposed Public Offering
August 03, 2020
From PR Newswire
Thinking about buying stock in Achieve Life Sciences, Applied DNA Sciences, Delta Air Lines, Carnival Corp, or MGM Resorts?
July 31, 2020
From PR Newswire
Achieve Announces Patent Granted in the U.S. for Novel Analogs of Cytisinicline for Use in CNS and Addiction Indications
July 31, 2020
From PR Newswire
Thinking about buying stock in Achieve Life Sciences, Regulus Therapeutics, Exela Technologies, FireEye Inc, or Intel Corp?
July 29, 2020
From PR Newswire
Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020
July 28, 2020
From PR Newswire
Thinking about buying stock in Zomedica Pharmaceuticals, iBio Inc, Achieve Life Sciences, Intec Pharma, or Apple Inc?
July 22, 2020
From PR Newswire
From PR Newswire
From PR Newswire
Achieve Reports Financial Results for First Quarter 2020 and Provides Update on Cytisinicline Development Program
May 14, 2020
From PR Newswire
From PR Newswire
From PR Newswire
Achieve Reports Financial Results for Fourth Quarter and Year-End 2019 and Provides Update on Cytisinicline Development Program
March 13, 2020
From PR Newswire
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.